| Literature DB >> 32392827 |
Anna Hotowy1, Marta Grodzik1, Marlena Zielińska-Górska1, Natalia Chojnacka1, Natalia Kurantowicz1, Sławomir Dyjak2, Barbara Strojny1, Marta Kutwin1, André Chwalibog3, Ewa Sawosz1.
Abstract
The characteristic features of nanomaterials provide rich opportunities for a broad range of applications due to their different physicochemical properties. Nanocolloidal silver and graphenic carbon materials differ in most physicochemical characteristics, except for their nanodimensions. Since there is a growing demand for stem cell therapies for coronary disorders, examining cardiac progenitor cells (CPC) in terms of their response to nanostructure treatment seems to be a reasonable approach. Morphological studies and viability assessments were performed with CPC in vitro, treated with small concentrations of silver nanoparticles (AgNP), hierarchical nanoporous graphenic carbon (HNC) and their mixtures. A viability test confirmed the morphological assessment of CPC treated with AgNP and HNC; moreover, the action of both nanomaterials was time-dependent and dose-dependent. For AgNP, between the two of the applied concentrations lies a border between their potential beneficial effect and toxicity. For HNC, at a lower concentration, strong stimulation of cell viability was noted, whereas a higher dosage activated their differentiation. It is necessary to perform further research examining the mechanisms of the action of AgNP and especially of unexplored HNC, and their mixtures, on CPC and other cells.Entities:
Keywords: cardiac progenitor cells; chicken; hierarchical nanoporous graphenic carbon; nanobiotechnology; silver nanoparticles
Year: 2020 PMID: 32392827 PMCID: PMC7254322 DOI: 10.3390/ma13092159
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Morphology and structure of nanomaterials and their mixture: (A) silver nanoparticles; (B) carbon nanostructures (hierarchical nanoporous graphenic carbon (HNC)); (C,D) the mixture of silver nanoparticles and carbon nanostructure.
The results of measuring the zeta potential of suspensions: of silver nanoparticles (AgNP), carbon nanostructures (HNC) and the mixture of silver nanoparticles and carbon nanostructure (AgNP + HNC).
| Nanostructures | Concentration (µg/mL) | Zeta Potential (mV) |
|---|---|---|
| AgNP | 2 | −14.3 |
| AgNP | 10 | −20.0 |
| HNC | 0.4 | −11.2 |
| HNC | 2 | −12.2 |
| AgNP + HNC | 2 + 0.4 | −15.4 |
| AgNP + HNC | 10 + 2 | −13.3 |
Figure 2(a) Zeta potential of individual media with nanostructures. (b) pH values of individual media with nanostructures. (A) control medium; (B) medium with 2 µg/mL AgNP; (C) medium with 10 µg/mL AgNP; (D) medium with 0.4 µg/mL HNC; (E) medium with 2 µg/mL HNC; (F) medium with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) medium with 10 µg/mL AgNP and 2 µg/mL HNC. a–c Statistically significant differences (p < 0.0001).
The mean viability level of cardiac progenitor cells (CPC) culture in timepoints. (A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. a–c Statistically significant differences (p < 0.0001). All the data presented as mean fluorescence intensity (MFI).
| Time | Treatment | Mean Value in Time Point | Standard Error | ||||||
|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | |||
| 2 h | 538 | 766 | 783 | 798 | 524 | 693 | 956 | 723 a | 139 |
| 24 h | 9680 | 11,381 | 745 | 13,749 | 11,866 | 9880 | 1019 | 8251 b | 139 |
| 48 h | 17,815 | 21,449 | 464 | 23,609 | 19,004 | 17,830 | 843 | 14,248 c | 139 |
Figure 3Cardiac progenitor cell morphology and viability after 2 h of culture with AgNP and HNC; (A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual experimental groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05). Arrows indicate agglomerates of HNC. Magnification 100×. Scale bars 200 µm. MFI—mean fluorescence intensity.
Figure 4Cardiac progenitor cell morphology and viability after 24 h of culture with AgNP and HNC; (A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual experimental groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05). Magnification 100×. Scale bars 200 µm. MFI—mean fluorescence intensity.
Figure 5Morphology of cardiac progenitor cells cultured with the addition of 10 μg/mL AgNP after 24 h. Magnifications: (A) 100×; (B) 200×; (C) 400×.
Figure 6Cardiac progenitor cell morphology and viability after 48 h of culture with AgNP and HNC; (A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC. (A–G) Series of viability in individual experimental groups measured as fluorescence. a–d Statistically significant differences (p ≤ 0.05). Magnification 100×. Scale bars 200 µm. MFI—mean fluorescence intensity.
Figure 7Morphology of cardiac progenitor cells cultured with the addition of 10 μg/mL AgNP after 48 h. Magnifications: (A) 100×; (B) 200×; (C) 400×.
Cardiac progenitor cells relative viability fold change depending on time and treatment, compared to the control group; (A) control culture; (B) culture with 2 µg/mL AgNP; (C) culture with 10 µg/mL AgNP; (D) culture with 0.4 µg/mL HNC; (E) culture with 2 µg/mL HNC; (F) culture with 2 µg/mL AgNP and 0.4 µg/mL HNC; (G) culture with 10 µg/mL AgNP and 2 µg/mL HNC.
| Time | Treatment | ||||||
|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | |
| 2 h | 1 | 1.42 | 1.46 | 1.48 | 0.98 | 1.29 | 1.78 |
| 24 h | 1 | 1.18 | 0.08 | 1.42 | 1.23 | 1.02 | 0.11 |
| 48 h | 1 | 1.20 | 0.03 | 1.33 | 1.07 | 1.00 | 0.05 |